Large-scale multiancestry genome-wide association studies have identified hundreds of loci associated with type 2 diabetes (T2D) and glycemic traits, yet imputed genotyping arrays limit the detection of low-frequency and rare variants. Whole-genome sequencing (WGS) offers a more complete view of genetic variation, especially across diverse populations. We analyzed high-coverage (38×) WGS data from 21,913 T2D […]
Read MoreCategory: Diabetes
Type 2 Diabetes Reduces IFN-α2 and Compromises Antiviral Defense: Evidence From Mendelian Randomization and H1N1-Infected Diabetic Mice
Type 2 diabetes (T2D) impairs antiviral immunity; however, the causal link between T2D and interferon-α2 (IFN-α2) deficiency remains unclear. This study used genome-wide association study–based Mendelian randomization (MR) to investigate this relationship and validated the findings in an H1N1-infected diabetic mouse model. MR analysis of 26 single nucleotide polymorphisms showed a significant negative association between […]
Read MoreDiabetes Spotlight: Erin Mulvilhill, PhD—Modeling Diabetes and Cardiovascular Disease for Patient-Driven Outcomes
Home to the headwaters of nine rivers, Algonquin Provincial Park contains thousands of lakes and hundreds of miles of streams, waterways that historically have played a crucial role in Ontario’s lumber industry. During her second year of undergraduate studies at the University of Western Ontario, Erin Mulvihill did a research project sampling benthic invertebrates, the […]
Read MoreStatement of Retraction. Yunzhou Dong, Miao Zhang, Shuangxi Wang, Bin Liang, Zhengxing Zhao, Chao Liu, Mingyuan Wu, Hyoung Chul Choi, Timothy J. Lyons, and Ming-Hui Zou. Activation of AMP-Activated Protein Kinase Inhibits Oxidized LDL-Triggered Endoplasmic Reticulum Stress In Vivo. Diabetes 2010;59:1386–1396. DOI: 10.2337/db09-1637 . PMID: 20299472. PMCID: PMC2874699
At the request of the University of Oklahoma Health Campus, the above-cited article has been retracted by the American Diabetes Association (ADA), the publisher of Diabetes, to correct the research record due to unreliable data. Source link
Read MoreStatement of Retraction. Shuangxi Wang, Jian Xu, Ping Song, Benoit Viollet, and Ming-Hui Zou. In Vivo Activation of AMP-Activated Protein Kinase Attenuates Diabetes-Enhanced Degradation of GTP Cyclohydrolase I. Diabetes 2009;58:1893–1901. DOI: 10.2337/db09-0267 . PMID: 19528375. PMCID: PMC2712774
Statement of Retraction. Shuangxi Wang, Jian Xu, Ping Song, Benoit Viollet, and Ming-Hui Zou. In Vivo Activation of AMP-Activated Protein Kinase Attenuates Diabetes-Enhanced Degradation of GTP Cyclohydrolase I. Diabetes 2009;58:1893–1901. DOI: 10.2337/db09-0267 . PMID: 19528375. PMCID: PMC2712774 Source link
Read MoreIssues and Events
Issues and Events Source link
Read MoreSpecial Edition: What's Next—Once-Weekly Insulins—Mechanisms and Practical Considerations
Continuing his exploration of once-weekly insulins, Neil Skolnik speaks with Aaron King, MD. Together, they cover the mechanisms, practical considerations, and the myriad benefits that this new therapy can have over daily basal insulin. This special episode is sponsored with support from Novo. Please listen to the episodes by clicking on the podcast player below […]
Read MoreSpecial Edition: What's Next—CKD in Type 1 Diabetes—An Urgent Need for Therapies
There is a fundamental link between diabetes and kidney care. But while there are many medications available to improve CKD outcomes in people with type 2 diabetes, the same options are not available for people with type 1. In this special episode, Dr. Neil Skolnik speaks with Janet McGill, MD, MA, FACE, FACP about the […]
Read MoreEfficacy and safety of CagriSema & Retatrutide, CGM benefits beyond T2D, & more!
Welcome to the latest episode (July 2026) of DOC Updates, where every month Neil Skolnik, MD and John Russell, MD review the most important articles on diabetes, obesity, and cardiometabolic disease. This month on DOC Updates: Aroda V, Buzzetti R, Dalskov S et al. “Efficacy and safety of once-weekly cagrilintide–semaglutide (CagriSema) in adults with type […]
Read MoreSpecial Edition: Medications in the Pipeline for Cardiometabolic Disease
In this special edition of DOC Updates, Neil Skolnik speaks with Dr. Juan Frias, who catalogues the latest cardiometabolic medications, emphasizing the distinguishing characteristics of each. This special episode is sponsored with support from Lilly. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, […]
Read More